Analyst Price Targets — LMAT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 6, 2026 12:43 pm | Frank Takkinen | Lake Street | $135.00 | $105.37 | TheFly | LeMaitre price target raised to $135 from $110 at Lake Street |
| May 6, 2026 11:35 am | — | Barrington | $120.00 | $112.00 | TheFly | LeMaitre price target raised to $120 from $105 at Barrington |
| November 10, 2025 2:16 pm | Ross Osborn | Cantor Fitzgerald | $95.00 | $86.96 | StreetInsider | Cantor Fitzgerald Reiterates Neutral Rating on LeMaitre Vascular (LMAT) |
| November 5, 2025 9:22 am | — | Roth Capital | $108.00 | $87.26 | TheFly | LeMaitre resumed with a Buy at Roth Capital |
| February 28, 2025 1:53 pm | — | Lake Street | $110.00 | $91.85 | TheFly | LeMaitre price target raised to $110 from $105 at Lake Street |
| October 15, 2024 6:11 am | Ross Osborn | Cantor Fitzgerald | $96.00 | $92.14 | TheFly | LeMaitre initiated with a Neutral at Cantor Fitzgerald |
| August 20, 2024 5:54 am | Daniel Stauder | JMP Securities | $100.00 | $85.53 | TheFly | LeMaitre price target raised to $100 from $77 at JMP Securities |
| April 26, 2024 3:03 am | Rick Wise | Stifel Nicolaus | $75.00 | $65.46 | StreetInsider | Stifel Upgrades LeMaitre Vascular (LMAT) to Buy |
| September 6, 2023 3:04 pm | Suraj Kalia | Oppenheimer | $70.00 | $56.71 | Benzinga | Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating |
Latest News for LMAT
BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
I don't love valuation models because they rely on assumptions, and assumptions can be dangerous. But we still need to pay attention. I sold my position in BIPC not because I don't like the stock or that I'm spooked by recent movement, but rather in the optic of portfolio simplification. Since I started this portfolio in September 2017, I have received a total of $36,444.54 CAD in dividends.
CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LMAT.
U.S. House Trading
No House trades found for LMAT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.